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 Abstract 
People with HIV experience a high prevalence and burden of symptoms throughout their 
disease trajectory. These have important public and clinical health implications. We 
aimed to measure: the seven-day period prevalence of symptoms, the most burdensome 
symptoms, and determine if symptom burden is associated with treatment status, 
clinical stage and physical performance.  
We conducted a cross-sectional study among adult (aged at least 18 years) patients with 
HIV, attending outpatient care in Kenya. Data was gathered through self-report using 
the Memorial Symptom Assessment Scale-Short Form (MSAS-SF), file extraction 
(sociodemographic and clinical data) and through observation using the Karnofsky 
Performance Scale. Multivariable ordinal logistic regression assessed the association of 
symptom burden controlling for demographic and clinical variables.  
Of the 475 participants approached, 400 (84.2%) participated. Ordinal logistic regression 
showed that being on HIV treatment was associated lower global distress index (in 
quartiles) (odds ratio .45, 95% CI .23 to .88; p=0.019).  
Pain and symptom burden still persist in the era of antiretroviral therapy. Routine clinical 
practice should incorporate assessment and management of pain and symptoms 
irrespective of disease stage and treatment status in order to achieve the proposed 
fourth ‘90’ in the UNAIDS 90-90-90 targets (that is good quality of life).  
 
Introduction and background 
 
Kenya is one of the countries in the sub-Saharan region with a high prevalence of HIV 
infection. It shares fourth position alongside Mozambique and Uganda in terms of HIV 
prevalence. UNAIDS estimates that at the end of 2015, there were 1.5 million people 
living with HIV in Kenya with 5.9% adult prevalence (WHO/UNAIDS, 2015). Kenya has 
made positive strides in terms of implementing the 90-90-90 UNAIDS policy. At the end 
of 2015, 64% of the population were on HIV treatment. Death rate declined from 51,000 
in 2010 to 36,000 in 2015. 
Despite the availability of HIV treatment to optimise care for people living with HIV 
(PLWA), multi-dimensional problems still persist. Patients with HIV experience physical, 
psychological, social and spiritual problems from the point of diagnosis (Simms et al., 
2011) within two weeks of diagnosis (Simms et al., 2013) and during treatment (Harding 
et al., 2006, Harding et al., 2010). Our prior evidence from the UK, South Africa and 
Uganda have demonstrated a high prevalence and burden of problems in outpatient 
settings alongside ART (Harding et al., 2010, Namisango et al., 2012, Farrant et al., 
2012).  These problems have negative effects on the life of the patients (Harding et al., 
2012a).  
Clinicians and policy makers are increasingly recognising that patient self-reported 
outcomes are essential to ensure optimal health service access and equity in health 
status (Dawson et al., 2010). A whole person-centred approach to HIV treatment, care 
and support is essential to optimise outcomes, and is advocated in global policy for those 
with any stage of HIV infection and alongside treatment (WHO, 2011). WHO advocates 
for pain and symptom control in HIV clinical care as essential components within the 
package of care (WHO, 2011).  
The clinical and public health relevance of these problems are demonstrated in the 
relationship between symptom burden (physical and psychological) and sexual risk 
taking (Harding et al., 2012b) poor adherence to treatment (Sherr et al., 2008), and 
viral rebound (Lampe et al., 2010). Symptoms in HIV are present throughout the disease 
trajectory regardless of CD4 count and stage classification (Peltzer and Phaswana-
Mafuya, 2008, Willard et al., 2009). The burden of symptoms has not been carefully 
examined in terms of its association with clinical staging and treatment status. Symptom 
burden in HIV is associated with poor drug adherence and poor quality of life (Harding et 
al., 2010, Hughes et al., 2004, Brechtl et al., 2001, Rosenfeld et al., 1996), We therefore 
conducted a cross-sectional study on living with HIV in order to examine the seven day 
prevalence of physical and psychological symptoms among PLWH and determine if 
symptom burden was associated with treatment status and clinical stage of illness,  to 
inform the development of self-management interventions in HIV and new clinical 
guidelines in the management of pain and symptoms. Given wider roll out of effective 
treatments, the paucity of recent data on pain and symptoms among PLWH, and the 
increasing focus on patient-reported outcomes and quality of life, this study is timely to 
ensure that HIV treatment and care services can respond to patient needs and concerns.  
 
Methods 
 
We did a cross-sectional study using self-reported data, file extraction and observer 
ratings. Participants were included if they were adult (aged at least 18 years) patients 
with documented HIV diagnosis, and aware of their diagnosis. Participants were recruited 
at an HIV outpatient care facility (Bomu hospital) in Mombasa, Kenya. Bomu hospital 
offers a wide range of services for HIV patients such as counselling and testing, inpatient 
and outpatient treatment of HIV for both adults and children. The hospital also provides 
medical services for patients with other medical conditions such as lung disease, 
diabetes, malaria. Ethical approval was obtained from the Kenyan Medical Research 
Institute (KEMRI/RES/7/3/1). 
Procedures  
The researcher used a random number table each day to select the first patient to 
approach in the patient outpatient queue. Each patient approached had the information 
sheet read aloud. They were then asked to make an informed decision to take part in the 
study. If they were willing to take part, they were asked to sign the consent form. The 
researcher subsequently approached every consecutive patient. The researcher recorded 
the number of acceptances and refusals daily, in order to calculate the response rate. A 
payment of $5 was made for patient expenses in relation to participation in the study, 
and a drink/fruit snack was offered. The researcher is a highly experienced Kenyan 
researcher who has worked in this setting with this population on several previous 
studies of people living with HIV (Lowther et al., 2012, Lowther et al., 2015b), and is 
fluent in local languages.  
Sample size calculation 
Sample size calculation was based on HIV prevalence in Kenya. UNAIDS data report that 
1.5 million Kenyans are infected with HIV (95% CI 1.3m, 1.6m) (WHO/UNAIDS, 2015). 
With 95% confidence, 5% margin of error, and a response distribution of 50% for any 
outcome we estimated that 385 were required to determine prevalence of any outcome. 
We therefore recruited 400 to allow for any non-completers.  
Data collection 
The researcher extracted CD4, treatment status for HIV and TB from patient’s records.  
The researcher administered questionnaires to gather self-reported data in a private 
space at the clinic. All responses were recorded by the researcher and answers given 
verbally by participants. This helped to reduce any potential response bias by mixing 
self-completion and researcher-completion. Data were collected using tools previously 
implemented/validated in African in HIV populations. The tools were: 
1. The Memorial Symptom Assessment Scales Short Form (MSAS-SF) was used to assess 
symptoms. MSAS-SF measured the prevalence and burden of physical and psychological 
symptoms in the past seven days (Chang et al., 2000). MSAS-SF has three subscale 
indices of physical symptom distress (MSAS-PHYS), psychological symptom distress 
(MSAS-PSYCH) and global distress index (MSAS-GDI), each has a score range of 0-4. It 
is applicable in a wide range of conditions, and enables comparison between conditions 
(Harding et al., 2010). It was recently used in symptom cluster studies among HIV 
patients conducted in Uganda and South Africa (Moens et al., 2015, Namisango et al., 
2015).  
2. Demographics, socioeconomic status using Demographic and Health Survey (DHS) 
(Gwatkin et al., 2007), using variables such as house construction, possession of items, 
fuel supply, and water source. These variables were used to calculate the wealth of the 
participants.  The wealth quintile variable was created in line with the methods of DHS 
(Gwatkin et al., 2007). We used factor analysis with principal component analysis to 
create a continuous variable which was then converted into quintile. DHS has previously 
been used in HIV research in sub-Saharan Africa (Lowther et al., 2012, Harding et al., 
2014).  
3. The Karnofsky Performance Status (KPS). This is an observer-rated scale widely been 
used in HIV population (Namisango et al., 2015). It is used to assess the level of 
physical function of the patient, rated on a scale of 0-100, with 0 corresponding to no 
physical function (death) and 100 corresponding to maximum independent functioning 
(Mor et al., 1984). The Karnofsky Performance Scale was previously used in a symptom 
cluster study among HIV patients in Uganda (Moens et al., 2015, Namisango et al., 
2015). 
Data analysis  
Data was entered into a spreadsheet with a unique identifier for each patient. The 
spreadsheet was converted into Stata version 14 dataset (StataCorp, 2015).  
The prevalence of each symptom and distress associated with each symptom was 
tabulated. All MSAS-SF subscales were computed and calculated based on the methods 
of the MSAS-SF. For the presence of physical symptoms they were computed as follows: 
0.8 ‘no distress at all’, 1.6 ‘a little bit’, 2.4 ‘somewhat’, 3.2 ‘quite a bit’ and 4.0 ‘very 
much’. For the presence of psychological symptoms they were computed as follows: 1 
‘rarely’ 2 ‘occasionary’ 3 ‘frequently’ and 4 ‘almost constantly’. Most distressing 
symptoms were calculated, these were symptoms scored using the worst two categories 
of burden (i.e., causes ‘quite a bit’ or ‘very much’ distress for physical symptoms and 
‘frequently’ or ‘almost constantly’ for psychological symptoms). Individuals under these 
two worst categories were regarded as experiencing high distress.  
MSAS-GDI, MSAS-PHYS and MSAS-PSYCH scores were not normally distributed. They 
were therefore converted into quartiles (MSAS-GDI) and quintiles (MSAS-PHYS and 
MSAS-PSYCH). CD4 count were converted into textiles We used this classification based 
on CD4 count cut-offs and the risks of opportunistic infections in line with a study 
conducted in Ethiopia (Damtie et al., 2013).   
 The KPS scores were skewed and were therefore converted into binary variable with two 
groups: (1) with a score of ≤80%, unable to carry normal activity or work (2) with a 
score of >80% ability to carry normal activity and work. This was based on a study by 
Peus et al (2013) who recommended to use an algorithm with a minimum of two and a 
maximum of three variables to facilitate an adequate and efficient evaluation of the KPS 
(Péus et al., 2013). Descriptive statistics were used to profile the demographic, 
socioeconomic and clinical characteristics of participants. 
The dependent outcomes were global distress index (MSAS-GDI), physical symptom 
distress (MSAS-PHYS) and psychological symptom distress (MSAS-PSYCH). Covariates 
were demographic variables (age, gender, education, and wealth in quintiles), clinical 
variables (HIV stage, CD4 count, TB treatment: yes/no, ART treatment: yes/no and 
KPS). Initially we conducted a univariate analysis for demographic, and clinical variables. 
We then conducted adjusted analysis for demographic variables falling within less than 
25% p value (Altman, 1991). Clinical variables (HIV treatment status, CD4 count, HIV 
clinical stage, TB treatment status) were forced into the multivariate models regardless 
of the outcome of the univariate analysis.  This is because these are confounding clinical 
variables frequently associated with HIV outcomes. We were interested in risk factor 
modelling not just prediction. Furthermore, after we retained clinical variables we 
produced richer models and assumptions met. Studies have shown that researchers can 
return confounding variables as long as sample sizes are larger because correct retention 
increases with sample size (Bursac et al., 2008). Physical symptoms such as pain occur 
due to HIV illness or HIV treatment (Marcus et al., 2000, Vogl et al., 1999), peripheral 
neuropathy due to TB infection and treatment (Chen et al., 2013, Evans et al., 2011, 
Ellis et al., 2010) CD4 count (Aouizerat et al., 2010, Richardson et al., 2009) and clinical 
stage (Martin et al., 1999, Dobalian et al., 2004, Nair et al., 2009) are frequently 
associated with HIV illness. We conducted a ‘brant’ test of parallel regression 
assumption. A non-significant test statistic provided evidence that the parallel regression 
assumption were met. All cases with missing data were excluded from the models.  
 
Results  
 
Table 1 presents the demographic and clinical characteristics of the participants. Of the 
475 participants approached, 400 (84.2%) participated. The mean age was 39.4 years 
(SD 9.9), range 18-74 years. The majority were females (n=280, 70%). Just over half of 
the sample (n=213, 53.25%) as attended primary school, and just over a quarter 
(n=113, 28.25%) attended secondary school.  
Treatment variables 
Treatment variables are presented on table 1. Most of the patients were currently on 
ART (n=366, 91.5%), with (n=61, 15.64%) also on TB treatment. The mean CD4 count 
was 393.7(SD=238.2). Most of the participants were on stage 3 of HIV infection (n=343, 
85.75%).  The majority of the patients disclosed their status to someone (n=373, 
93.25%).  In relation to the physical performance score (KPS) n=298 (74.5%) were 
above 80%.  
Symptoms reported  
The mean symptom distress subscale indices were: global distress index (GDI) 13.34 
(SD=10.06), physical symptom distress (PHYS) 12.52 (SD= 9.88) and psychological 
symptom distress (PSYCH) was 8.44 (SD=7.22). The ten most prevalent symptoms are 
presented on table 2. Pain was the most prevalent symptom reported (n=244, 61%), 
followed by feeling sad (n=235, 58.75%). Manifestations of fatigue were also most 
common, such as feeling drowsy (55.25%), difficulty in concentrating (55%) and lack of 
energy (55%). Other most prevalent symptoms were problems with sexual activity 
(54.24%), worry (49.5%), numbness (46.25%), feeling irritable (45%) and hunger 
(42.75%).    
The ten most distressing symptoms (worst two categories reported as “quite a bit” or 
“very much” for physical symptoms and “frequently” or “almost constantly” for 
psychological symptoms) were problems with sexual activity (71.43%),  hunger 
(69.58%), feeling nervous (66.86%),  feeling sad (63.83%), feeling irritable (62.73%), 
worry (59.59%), suicidal (53.45%), changes in the skin (53.22%), lack of sleep 
(53.15%), and feeling drowsy (49.77%).  
Predictors of symptom prevalence and distress 
Univariate and multivariate ordinal logistic regression models were constructed as shown 
on tables 3, 4 and 5.  
ART treatment, age, gender and KPS were significantly associated with global distress 
index (see table 3). Being on ART was associated with lower (better) global distress 
index (odds ratio .45, 95% CI .23 to .88; p=0.019. Women experienced worse global 
distress index (odds ratio 2.97, 95% CI 1.95 to 4.52; p<0.001). Age predicted lower 
global symptom distress (odds ratio .98, 95% CI .96 to 1.00; p=0.048). Participants 
with KPS >80% had lower (better) global distress index (odds ratio .32, 95% CI .20 to 
.50; p<0.001).  
Gender and KPS were associated with physical and psychological symptom distress. 
Women reported higher (i.e. worse) physical symptom distress (odds ratio 2.28, 95% CI 
1.52 to 3.41; p<0.001). Participants with KPS scores of >80% had lower physical (i.e. 
better) symptom distress (odds ratio .28, 95% CI .18 to .45; p<0.001) (see table 4).  
Likewise on table 5, women experienced higher (i.e. worse) psychological symptom 
distress (odds ratio 3.17, 95% CI 2.11 to 4.78; p<0.001). Patients with KPS scores of 
>80% were associated with lower (i.e. better) psychological symptom distress (odds 
ratio .43, 95% CI .28 to .67; p<0.001).  
In summary gender and KPS were associated with all the symptom subscales (GDI, 
PHYS and PSYCH).  
Discussion 
 
Data from this study shows that people with HIV attending outpatient clinic reported 
high prevalence of physical and psychological symptoms. Compared to other studies 
conducted in Uganda using the same measure in similar populations, our results are 
comparable in terms of the most prevalent symptoms (Wakeham et al., 2010, 
Namisango et al., 2013), although the prevalence was much higher in the Ugandan 
studies for pain (Wakeham et al., 2010), feeling drowsy, lack of energy (Namisango et 
al., 2013, Wakeham et al., 2010), numbness of feet and hands (Wakeham et al., 2010). 
However the prevalence was lower in another Ugandan study compared to our study for 
pain and  difficulty concentration (Namisango et al., 2013). Interestingly problems with 
sexual activity were rated the top most distressing symptom in all the studies. Other 
most distressing symptoms were feeling sad, worry, pain and lack of energy. Compared 
with similar work done in the UK, similar symptoms were reported and most prevalent 
were lack of energy, worry, problems with sexual activity and pain (Harding et al., 
2010). However, prevalence rates were higher in the UK study. The prevalence and 
burden of symptoms reported in our study are similar to those reported in a review by 
Solano and colleagues (Solano et al., 2006).  
Pain prevalence was high and among the most burdensome physical symptoms in our 
study. Several studies in HIV (Huang et al., 2013, Kolawole Wasiu and Alakija Kazeem, 
2011, Richardson et al., 2009, Kimball and McCormick, 1996, Wakeham et al., 2017) 
and cancer (Huang et al., 2013) population have reported high prevalence of pain 
alongside ART. Several authors have reported that pain and other physical and 
psychological symptoms persist in HIV alongside ART (Harding et al., 2010, Lowther et 
al., 2014).  
Being female and KPS >80% were associated with all the three MSAS subscales. 
Similarly a cross-sectional study conducted in Uganda reported that KPS>70% were 
associated with symptom burden of each MSAS subscale (Namisango et al., 2013). In 
our study being female was associated with higher physical, psychological and global 
distress and burden. Likewise a multi-country study in sub-Saharan Africa and an 
American sample concluded that females experienced higher symptom burden (Potter et 
al., 2003, Koole et al., 2016), however in the Ugandan study, being male was associated 
with psychological symptom distress (Namisango et al., 2013).  
Our results show that being on ART was associated with lower global distress index 
scores, however there was no significant association with physical and psychological 
distress measures. Similarly a recent longitudinal study conducted in Uganda among HIV 
patients using the same tool concluded that symptom prevalence and distress indices 
reduced after ART was initiated (Wakeham et al., 2017). However, our results are at 
odds with previous cross- sectional study conducted in UK and Uganda that reported that 
ART treatment is not associated with any symptom distress measure (Namisango et al., 
2013, Harding et al., 2010).   
Our findings show that prevalence and distress of symptoms were not associated with 
CD4 count and clinical stage. Similarly a  cross-sectional study conducted in Uganda in 
the same population reported that CD4 count and clinical stage were not associated with 
symptom burden (Wakeham et al., 2010). This is contrary to findings from a 
heterogeneous HIV infected American population that reported higher pain prevalence 
among patients with low CD4 count (Richardson et al., 2009, Aouizerat et al., 2010) and 
higher pain prevalence among patients with advanced HIV infection (Martin et al., 1999, 
Dobalian et al., 2004, Nair et al., 2009) and higher symptom burden at stage IV 
(Namisango et al., 2013). Our findings therefore are important to inform policy that pain 
and symptom management is critical at each stage of the infection and regardless of CD4 
count.  
The current study shows that hunger was one of the top ten prevalent symptoms and 
top five most distressing symptoms. This requires holistic patient-centred care and more 
attention because hunger may result in poor drug adherence (Harding et al., 2010). A 
recent longitudinal study reported that prior to starting ART hunger prevalence was 
43%, and it remained the same after one year, suggesting that hunger does not 
decrease with ART (Wakeham et al., 2017). In an African context hunger is due to 
poverty and long distance to access the clinic including long waiting time to meet the 
doctor (Hardon et al., 2007). A recent multi-country study conducted in Zambia, Uganda 
and Tanzania concluded that besides ART, not having enough food were the cause of 
hunger, and this led to poor drug adherence (Koole et al., 2016). ART provision and food 
integration should be encouraged in Kenya. A systematic review reported that provision 
of food supplements alongside ART reduces poor drug adherence (Singer et al., 2015).  
 
Study strengths and limitations 
We used questionnaires validated in local population and researcher administered the 
questionnaires. Our study provides novel data on symptom prevalence and burden 
among HIV patients through self-report. Our study had a response rate of 84.2 %.  
This study however has some limitations. This data was cross-sectional therefore, we 
can only determine associations. Data on viral load was missing in the patient records, 
although it is notable that previous studies have shown that higher viral load is 
associated with poor physical function (Nieves-Lugo et al., 2017), high burden of 
symptoms and low CD4 count (Richardson et al., 2002, Cox et al., 2018).   
Our novel data informs care delivery to support the guidelines for providing pain and 
symptom management for patients with HIV. 
Conclusion 
 
The prevalence and burden of physical and psychological symptoms persist in HIV 
particularly among women. The burden of hunger needs attention and further work to 
identify strategies to deal with this symptom in order to prevent poor drug adherence 
and attrition from HIV care.  
HIV clinical care is evolving from a medical model for delivery of effective treatments to 
person-centred care that addresses patient-reported outcomes. Recent evidence 
suggests that not only is pain more prevalent among PLWH compared to matched 
controls, but is associated with poorer function and lost days of employment (Sabin et 
al., 2018).  
If we are to achieve the proposed fourth “90” in the UNAIDS 90x90x90 targets, i.e. good 
quality of life for people living with HIV (Lazarus et al., 2016), then careful assessment 
of pain and symptoms must be a priority. This requires the replication of simple 
interventions to deliver person-centred HIV outpatient care (Logie and Harding, 2005b, 
Lowther et al., 2018a, Lowther et al., 2018b, Lowther et al., 2016, Lowther et al., 
2015a), strategies to ensure pain relieving drugs are available in pharmacies and are 
prescribed (Logie and Harding, 2005a), and that low cost, effective  interventions such 
as pain self-management for people living with HIV are delivered (Nkhoma et al., 2018, 
Nkhoma et al., 2015).  
Importantly, our data highlight the important of self-reported outcomes from diagnosis 
until the end of life. Routine clinical practice should incorporate assessment and 
management of pain and symptoms irrespective of disease stage and treatment status, 
given their high prevalence and burden.  
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